Skip to content

The observation study on the effect of low dose glucocorticoid (prednisone) on the blood glucose level and adverse pregnancy reaction in abortion patients.

The observation study on the effect of low dose glucocorticoid (prednisone) on the blood glucose level and adverse pregnancy reaction in abortion patients.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100046455
Enrollment
Unknown
Registered
2021-05-16
Start date
2020-03-01
Completion date
Unknown
Last updated
2022-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

recurrent spontaneous abortion, GDM

Interventions

Use glucocorticoid vs not used glucocorticoid:Nil

Sponsors

Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Women of childbearing age aged 25-40 years; 2. Spontaneous abortion >=2 times; 3. Did not take glucocorticoid in the past 3 months.

Exclusion criteria

Exclusion criteria: 1. Diabetes was diagnosed before pregnancy. 2. Before pregnancy, it has been diagnosed as PCOS and other endocrine diseases that may affect its own glucose metabolism. 3. Glucocorticoid was used in the past 3 months. 4. Known HIV positive and / or screening visit, HBsAg or HCV antibody positive. 5. Liver disease was defined as ALT or AST > 3 ULN. 6. The malignant tumors occurred in the past 5 years (except for the skin squamous basal cell carcinoma which has been resected and considered cured). Subjects who developed malignancies five years ago should provide evidence of remission or cure. Subjects with a history of cervical cancer who had undergone conization or cure in the past 3 years were eligible. 7. Patients with a history of chronic infection such as Mycoplasma, chlamydia, Cryptococcus and invasive fungal infection should be discussed with the main researchers. 8. History of active tuberculosis (TB) or evidence of previous TB infection. Subjects with a history of potential TB infection should also be excluded, unless there is a documented evidence that they have completed appropriate anti TB treatment in accordance with CDC guidelines or local regulations before screening. In addition, subjects were strictly forbidden to have any clinical symptoms / signs of active TB.

Design outcomes

Primary

MeasureTime frame
Blood glucose level;

Secondary

MeasureTime frame
C peptide;Glycosylated Hemoglobin;Obstetric complications;Fetal outcomes;

Countries

China

Contacts

Public ContactAimin Zhao

Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine

zamzkh0526@126.com+86 13917981090

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026